Aspireon Wealth Advisors Johnson & Johnson Transaction History

Aspireon Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $23,709 - $26,608	148 Added 3.07%	4,966 $859,000
Q3 2022 Nov 18, 2022	SELL	$161.33 - $179.52 $2.15 Million - $2.39 Million	-13,303 Reduced 73.41%	4,818 $787,000
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $2.11 Million - $2.35 Million	13,063 Added 258.26%	18,121 $155,000
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $25,060 - $27,715	149 Added 3.04%	5,058 $898,000
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $11,466 - $12,742	-71 Reduced 1.43%	4,909 $793,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $794,210 - $851,928	4,980 New	4,980 $820,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Aspireon Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Aspireon Wealth Advisors with notifications on news.